Ratings by B.Riley (Chad L. Mabry)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
2/8/2024 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
12/6/2023 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
12/1/2023 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
11/9/2023 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
9/26/2023 | Intercept Pharmaceuticals | ICPT | Downgrade | Neutral (Buy) |
10.44 (19.00) |
81.99% | Details | |
8/10/2023 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
5/30/2023 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
2/8/2023 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
11/30/2022 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
8/22/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
8/12/2022 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
7/28/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
7/14/2022 | Fortress Biotech | FBIO | Maintain | Buy (N/A) |
|
Details | ||
5/13/2022 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
1/24/2022 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
1/11/2022 | Intercept Pharmaceuticals | ICPT | Upgrade | Buy (Neutral) |
15.03 (19.00) |
26.41% | Details | |
9/7/2021 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
8/3/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (N/A) |
|
Details | ||
6/30/2021 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
6/16/2021 | Fortress Biotech | FBIO | Maintain | Buy (N/A) |
|
Details | ||
5/25/2021 | Intercept Pharmaceuticals | ICPT | Downgrade | Neutral (Buy) |
16.30 (19.00) |
16.56% | Details | |
4/5/2021 | Fortress Biotech | FBIO | Maintain | Buy (N/A) |
|
Details | ||
2/17/2021 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
2/8/2021 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
2/1/2021 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
1/15/2021 | Arcturus Therapeutics | ARCT | Downgrade | Neutral (Buy) |
62.27 (68.94) |
10.71% | Details | |
12/7/2020 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
12/4/2020 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
11/20/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
11/17/2020 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
10/12/2020 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
10/9/2020 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
8/31/2020 | Acasti Pharma | ACST | Downgrade | Neutral (Buy) |
0.71 (3.19) |
349.3% | Details | |
8/21/2020 | Fortress Biotech | FBIO | Maintain | Buy (N/A) |
|
Details | ||
8/5/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
8/5/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
7/31/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
6/29/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
4/24/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
2/28/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
2/27/2020 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details |